Tokyo, July 20, 2006 (JCN) - Seikagaku, a Tokyo company specializing in the study of intra-articular injection of hyaluronic acid, will begun conducting phase III clinical trials of Gel-200, a new hyaluronic acid gel for intra-articular injection in knee osteoarthritis patients, in the US in August.
